Fiscal Period | 2024 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 24 | Mar 23 | Mar 22 |
Revenue | 1,375.80 | 1,375.80 | 1,115.23 | 923.06 |
Total Revenue | 1,375.80 | 1,375.80 | 1,115.23 | 923.06 |
Costof Revenue Total | 482.61 | 482.61 | 509.32 | 433.23 |
Gross Profit | 893.19 | 893.19 | 605.91 | 489.84 |
Selling/ General/ Admin Expenses Total | 245.91 | 245.91 | 314.24 | 249.18 |
Research Development | 189.60 | 189.60 | 178.03 | 187.71 |
Depreciation/ Amortization | 63.93 | 63.93 | 57.12 | 53.87 |
Other Operating Expenses Total | 270.10 | 270.10 | 8.16 | 8.78 |
Total Operating Expense | 1,081.50 | 1,081.50 | 906.69 | 763.91 |
Operating Income | 294.30 | 294.30 | 208.54 | 159.15 |
Interest Inc( Exp) Net- Non- Op Total | -87.74 | -87.74 | 131.10 | 201.04 |
Other Net | 58.75 | 58.75 | 15.74 | 15.46 |
Net Income Before Taxes | 344.27 | 344.27 | 237.49 | 195.24 |
Provisionfor Income Taxes | 86.01 | 86.01 | 58.21 | 48.74 |
Net Income After Taxes | 258.26 | 258.26 | 179.28 | 146.51 |
Net Income Before Extra Items | 258.26 | 258.26 | 179.28 | 146.51 |
Net Income | 258.26 | 258.26 | 179.28 | 146.51 |
Income Availableto Com Excl Extra Ord | 258.26 | 258.26 | 179.28 | 146.51 |
Income Availableto Com Incl Extra Ord | 258.26 | 258.26 | 179.28 | 146.51 |
Diluted Net Income | 258.26 | 258.26 | 179.28 | 146.51 |
Diluted Weighted Average Shares | 9.60 | 9.60 | 9.60 | 9.60 |
Diluted EPS Excluding Extra Ord Items | 26.90 | 26.90 | 18.67 | 15.27 |
Diluted Normalized EPS | 26.90 | 26.90 | 18.66 | 15.23 |
Interest Exp( Inc) Net- Operating Total | - | - | 0.43 | 0.79 |
Gain( Loss)on Saleof Assets | - | - | 1.00 | 5.31 |
DPS- Common Stock Primary Issue | - | - | 3.00 | 2.50 |
Poly Medicure Dividend Poly Medicure Bonus Poly Medicure News Poly Medicure AGM Poly Medicure Rights Poly Medicure Splits Poly Medicure Board Meetings Poly Medicure Key Metrics Poly Medicure Shareholdings Poly Medicure Balance Sheet Poly Medicure Cashflow Poly Medicure Q1 Results Poly Medicure Q2 Results Poly Medicure Q3 Results Poly Medicure Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks